Red Light Therapy (Photobiomodulation) for Arthritis: A Comprehensive Overview

Arthritis, including rheumatoid arthritis (RA) and osteoarthritis (OA), significantly diminishes the quality of life for individuals globally, leading to considerable pain and disability [1]. Traditional treatments often come with side effects, increasing the burden on patients [1]. Photobiomodulation (PBM), also known as low-level light therapy (LLLT), has emerged as a promising alternative treatment for arthritis [1].
What is Red Light Therapy/PBM?
PBM involves the use of near-infrared light emitted by lasers or light-emitting diodes (LEDs) [1]. Unlike treatments that rely on heat, PBM triggers a photobiological response in cells, modulating their function and reducing inflammation [1].
How Does Red Light Therapy Work for Arthritis?
- Reduces Inflammation: PBM’s anti-inflammatory properties have been demonstrated in numerous studies, making it effective in arthritis treatment [1]. Studies using animal models have shown that LLLT can reduce inflammation in induced arthritis [2, 3]. For example, LLLT has been shown to reduce vascular permeability and edema formation in rats with zymosan-induced arthritis [4].
- Modulates Immune Response: LLLT can alter the inflammatory course of arthritis by stimulating immune cells [5]. It can also modulate the expression of matrix metalloproteinases (MMPs), which are responsible for the breakdown of cartilage and joint tissues in rheumatic disorders [6].
- Pain Relief: The analgesic effects of LLLT can help reduce pain associated with arthritis [7].
- Restores Muscle Strength: LLLT and resistance exercise have been shown to restore muscle strength in rats with experimentally induced RA [8].
Scientific Evidence
Numerous studies, including animal experiments and clinical trials, have reported the anti-inflammatory and joint function recovery effects of PBM in arthritis treatment [1].
- LLLT with laser wavelengths of 685 nm and 830 nm significantly inhibited edema formation, vascular permeability, and hyperalgesia in rats with zymosan-induced arthritis [4].
- In a murine model, LILT (low-intensity laser therapy) demonstrated anti-inflammatory effects for chronic arthritis and reduced resorption area [3]. The 905 nm laser showed better results for anti-inflammatory effect in acute arthritis, and the 660 nm laser showed better results in chronic arthritis [3].
- In another study on rats, LLLT at 670 nm reduced the inflammatory process and tissue injuries of the synovial membrane [9].
- Studies on mice have indicated that PBM can modulate both mRNA and protein expression of MMPs and TIMP-2, decreasing MMP-9 protein expression and increasing TIMP-2 protein expression [6].
Parameters to Consider
Despite the positive results, there are still questions about specific parameters such as [1]:
- Wavelength
- Dose
- Power density
- Irradiation time
- Treatment site
Clinical Trials and Evaluation
Clinical trials often use various evaluation methods to assess the effectiveness of PBM [1]. These include measuring pain levels, joint stiffness, functional capacity, and overall quality of life [7].

Conclusion
Red light therapy shows promise as a non-invasive, non-thermal treatment for arthritis by reducing inflammation, modulating immune responses, and alleviating pain [1]. More studies are needed to determine optimal treatment parameters and to confirm its effectiveness in diverse patient populations [1].
Sources
[1] The Mechanisms and Efficacy of Photobiomodulation Therapy for Arthritis: A Comprehensive Review
[5] Photobiomodulation effects in metalloproteinases expression in zymosan-induced arthritis
[8] Modulation of immune response to induced-arthritis by low-level laser therapy
[9] Low-intensity laser therapy efficacy evaluation in FVB mice subjected to acute and chronic arthritis
[10] Anti-inflammatory effect of low-level laser and light-emitting diode in zymosan-induced arthritis
